• News
  • Signs of progress against the superbugs, but...
News - published on 21 Jan 2020

Signs of progress against the superbugs, but not yet at the scale needed

The 2020 Antimicrobial Resistance Benchmark evaluates how 30 pharmaceutical companies are limiting drug-resistance.

Amsterdam, the Netherlands, 21 January 2020 – A core group of pharmaceutical companies are making progress in tackling the spread of antimicrobial resistance, new findings from the 2020 Antimicrobial Resistance Benchmark indicate. However, although a few companies are expanding their efforts, change is not happening at the scale needed to radically impact the threat from drug resistance. 

Explore further

Get in touch

Back to top |